5 / 2018 / vol. 7
Kosmetologia Estetyczna
540
N
ARTYKUŁ NAUKOWY
DERMATOLOGIA
LITERATURA
1.
Sokołowska-Wojdyło M. Bielactwo od teorii do praktyki klinicznej. Dermatologia
po Dyplomie 2018: 1.
2.
Misterska M, Szulczyńska-Gabor J, Żaba R. Etiopatogeneza, obraz kliniczny i lecze-
nie bielactwa. Post Dermatol Alergol 2009, vol. 4: 212-223.
3.
Al-Harbi M. Prevalence of depression in vitiligo patients. Skinmed 2013, vol. 11(6):
327-330.
4.
Kemp E, Waterman E, Weetman A. Autoimmune Aspects of Vitiligo. Autoimmuni-
ty 2009, vol. 34(1): 65-77.
5.
Ongenae K, Van Geel N, Naeyaert J. Evidence for an Autoimmune Pathogenesis of
Vitiligo. Pigment Cell Research 2003, vol. 16: 90-100.
6.
Mason C, Gawkrodger D. Vitiligo presentation in adults. Clin. Exp. Dermatol. 2005,
vol. 30: 344-345.
7.
Kovacs S. Vitiligo. J. Am. Acad. Dermatol. 1998, vol. 38: 647-666.
8.
Dammak I, Boudaya S, Mansour R, et al. A comparative study of oxidant-antioxi-
dant status in stable and active vitiligo patients. Arch. Dermatol. Res. 2006, vol. 298:
147-152.
9.
Mohammed G, Gomaa A, Al-Dhubaibi M. Highlights in pathogenesis of vitiligo.
World Journal of Clinical Cases 2015, vol. 3(3): 221-230.
10.
Hann S-K, Clinical variants of vitiligo. [w:] Lotti T, Hercogova J (red.). Vitiligo: Pro-
blems and Solutions. Problems and Solutions 2004: 159-173.
11.
Szepietowski J, Reich A. Leczenie chorób skóry i chorób przenoszonych drogą płcio-
wą. Wyd. PZWL, Warszawa 2008: 428-438.
12.
Gawkrodger D, Ormerod A, Shaw L, et al. Guideline for the diagnosis and manage-
ment of vitiligo. Br. J. Dermatol. 2008, vol. 159: 1051-1076.
13.
Braun-Falco O, Plewing G, Wolff H, Burgdorf W. Dermatologie und Venerologie.
Springer-Verlag, Berlin, Heidelberg 1996: 998-1002.
14.
Ezzedine K, Lim H, Suzuki T, et al. Revised classification/nomenclature of vitiligo
and related issues: the Vitiligo Global Issues Consensus Conference. Pigment cell &
melanoma research 2012, vol. 25(3): E1-13.
15.
Bishnoi A, Parsad D. Clinical and Molecular Aspects of Vitiligo Treatments. Interna-
tional Journal of Molecular Sciences 2018, vol. 19(5): 1509.
16.
Jabłońska S, Chorzelski T. Choroby skóry. Wyd. PZWL, Warszawa 2001: 434-436.
17.
Popko M, Kacalak-Rzepka A, Bielecka-Grzela S, Wesołowska J, Klimowicz A, Ma-
leszka R. Bielactwo nabyte jako problem estetyczny. Nieinwazyjne metody leczenia
bielactwa. Annalesacademiaemedicaestetinensis2011, vol. 57(3): 23-27.
18.
Wojas-Pelc A, Kaczorowska-Stawarz R, Knafel A. Bielactwo nabyte: proces mela-
nogenezy, etiopatogeneza, metody leczenia. Dermatol. Estet. 2005, vol. 7: 121-127.
19.
Sassi F, Cazzaniga S, Tessari G, Chatenoud L, Reseghetti A, Marchesi L, Girolomo-
ni G, Naldi L. Randomized controlled trial comparing the effectiveness of 308-nm
excimer laser alone or in combination with topical hydrocortisone 17-butyrate cre-
am in the treatment of vitiligo of the face and neck. Br. J. Dermatol. 2008, vol. 159(5):
1186-1191.
20.
Taïeb A, Picardo M. Clinical practice. Vitiligo. N. Engl. J. Med. 2009, vol. 360: 160-169.
21.
Esfandiarpour I, Ekhlasi A, Farajzadeh S, Shamsadini S. The efficacy of pimecroli-
mus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-
-blind, placebo-controlled clinical trial. J. Dermatolog. Treat. 2009, vol. 20(1): 14-18.
22.
Mahmoud B, Hexsel C, Hamzavi I. An Update on new and emerging options for the
treatment of vitiligo. Skin Therapy Lett. 2008, vol. 13: 1-6.
23.
Kullavanijaya P, LimH. Topical calcipotriene and narrowband ultraviolet B in the tre-
atment of vitiligo. Photodermatol. Photoimmunol. Photomed. 2004, vol. 20: 248-251.
24.
Ermis O, Alpsoy E, Cetin L, et al. Is the efficacy of psoralen plus ultraviolet a the-
rapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled
double-blind study. Br. J. Dermatol. 2001, vol. 145: 472-475.
25.
Rothstein B, Joshipura D, Saraiya A, Abdat R, Ashkar H, Turkowski Y, et al. Tre-
atment of vitiligo with the topical Janus kinase inhibitor ruxolitinib. J. Am. Acad.
Dermatol. 2017, vol. 76(6): 1054-1060.
26.
Matz H, Tur E. Vitiligo. Curr. Probl. Dermatol. 2007, vol. 35: 78-102.
27.
Bae J, Jung H, Hong B, Lee J, Choi W, Lee J, et al. Phototherapy for Vitiligo: A Syste-
matic Review and Meta-analysis. JAMA Dermatol. 2017, vol. 153(7): 666-674.
28.
Falabella R, Barona M. Update on skin repigmentation therapies in vitiligo. Pigment
Cell Melanoma Res. 2009, vol. 22: 42-65.
29.
Westerhof W, Nieuweboer-Krobotova L. Treatment of vitiligo with UV-B radiation
vs topical psoralen plus UV-A. Arch. Dermatol. 1997, vol. 133: 1591-1592.
30.
Taieb A, Alomar A, Böhm M, Dell’anna M, De Pase A, Eleftheriadou V, et al. Guide-
lines for the management of vitiligo: the European Dermatology Forum consensus.
Br. J. Dermatol. 2013, vol. 168(1): 5-19.
31.
Bae J, Yoo H, Kim H, Lee J, Kim G. Combination therapy with 308-nm excimer laser,
topical tacrolimus, and short-term systemic corticosteroids for segmental vitiligo:
A retrospective study of 159 patients. J. Am. Acad. Dermatol. 2015, vol. 73(1): 76-82.
32.
Grzanka A. Diagnostyka i leczenie bielactwa. Dermatol. Estet. 2009, vol. 11: 16-19.
33.
van Geel N, Speeckaert R, Taieb A, Picardo M, Böhm M, Gawkrodger D, et al. Koeb-
ner’s phenomenon in vitiligo: European position paper. Pigment Cell Melanoma Res.
2011, vol. 24(3): 564-573.
34.
van Geel N, Ongenae K, Naeyaert J. Surgical techniques for vitiligo: a review. Der-
matology 2001, vol. 202(2): 162-166.
35.
Pianigiani E, Andreassi A, Andreassi L. Autografts and cultured epidermis in the
treatment of vitiligo. Clin. Dermatol. 2005, vol. 23: 424-429.
36.
Gawkrodger D, Ormerod A, Shaw L, et al. Guideline for the diagnosis and manage-
ment of vitiligo. Br. J. Dermatol. 2008, vol. 159: 1051-1076.
37.
McGovern T, Bolognia J, Leffell J. Flip-top pigment transplantation: a novel trans-
plantation procedure for the treatment of depigmentation. Arch. Dermatol. 1999, vol.
135(11): 1305-1307.
38.
Camacho F, Mazuecos J. Treatment of vitiligo with oral and topical phenylalanine:
6 years of experience. Arch. Dermatol. 1999, vol. 135: 216-217.
39.
Sethi S, Mahajan B, Gupta R, et al. Comparative evaluation of the therapeutic effica-
cy of dermabrasion, dermabrasion combined with topical 5% 5-fluorouracil cream,
and dermabrasion combined with topical Placentrex® gel in localized stable vitiligo.
Int. J. Dermatol. 2007, vol. 46: 875-879.
40.
Yan R, Yuan J, Chen H, Li Y, Wu Y, Gao X, Chen H. Fractional Er:YAG laser assisting
topical betamethasone solution in combination with NB-UVB for resistant non-seg-
mental vitiligo. Lasers Med. Sci. 2017, vol. 32(7): 1571-1577.
41.
Grimes P, Miller M. Vitiligo: Patient stories, self-esteem, and the psychological bur-
den of disease. International Journal of Women’s Dermatology 2018, vol. 4(1): 32-37.
42.
Kanwar A, Kumaran M. Childhood Vitiligo: Treatment Paradigms. Indian Journal
of Dermatology 2012, vol. 57(6): 466-474.
